Enterocolitis necrotizante

BIBLIOGRAFIA

1. Obladen M. Necrotizing enterocolitis‑150 years of fruitless search for the cause. Neonatology 2009; 96:203‑10.

2. Ahle M, Drott P, Andersson RE. Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987‑2009. Pediatrics 2013; 132:e443‑51.

3. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009; 44:1072‑5.

4. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255‑64.

5. Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.

Pediatrics 2005; 115:696‑703.

6. Bedrick AD. Necrotizing enterocolitis: Neurodevelopmental “risky business”. J Perinatol 2004; 24:531‑3.

7. Mizrahi A, Barlow O, Berdon W, Blanc WA, Silverman WA. Necrotizing enterocolitis in premature infants. J Pediatr 1965; 66:697‑705.

8. Hull MA, Fisher JG, Gutierrez IM, Jones BA, Kang KH, Kenny M, et al. Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: A prospective cohort study. J Am Coll Surg 2014; 218:1148‑55.

9. Gordon PV, Clark R, Swanson JR, Spitzer A. Can a national dataset generate a nomogram for necrotizing enterocolitis onset? J Perinatol 2014; 34:732‑5.

10. Hunter CJ, Podd B, Ford HR, Camerini V. Evidence vs. experience in neonatal practices in necrotizing enterocolitis. J Perinatol 2008; 28 Suppl 1:S9‑13.

11. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997; 87:2026‑31.

12. Yee WH, Soraisham AS, Shah VS, Aziz K, Yoon W, Lee SK; Canadian Neonatal Network. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics

2012; 129:e298‑304.

13. Kawase Y, Ishii T, Arai H, Uga N. Gastrointestinal perforation in very low birth weight infants. Pediatr Int 2006; 48:599‑603.

14. Guner YS, Friedlich P, Wee CP, Dorey F, Camerini V, Upperman JS. State-based analysis of necrotizing enterocolitis outcomes. J Surg Res 2009; 157:21-9.

15. Lambert DK, Christensen RD, Henry E, Besner GE, Baer VL, Wiedmeier SE, et al. Necrotizing enterocolitis in term neonates: Data from a multihospital health care system. J Perinatol 2007; 27:437‑43.

16. Maayan Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing enterocolitis in full term infants: Case control study and review of the literature. J Perinatol 2004; 24:494‑9.

17. Ostlie DJ, Spilde TL, St Peter SD, Sexton N, Miller KA, Sharp RJ, et al. Necrotizing enterocolitis in full term infants. J Pediatr Surg 2003;38:1039‑42.

18. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, et al. Adverse effects of early dexamethasone in extremely‑low‑birth‑weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344:95‑101.

19. Gordon PV, Young ML, Marshall DD. Focal small bowel perforation: An adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 2001; 21:156‑60.

20. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (2) Two populations of patients with perforations. J Perinatol 2006;26:185‑8.

21. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends in acquired neonatal intestinal disease: Is it time to abandon Bell’s criteria? J Perinatol 2007; 27:661‑71.

22. Feuille E, Nowak Wegrzyn A. Definition, etiology, and diagnosis of food protein induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2014; 14:222‑8.

23. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:119 29.

24. Coviello C, Rodriquez DC, Cecchi S, Tataranno ML, Farmeschi L, Mori A, et al. Different clinical manifestation of cow’s milk allergy in two preterm twins newborns. J Matern Fetal Neonatal Med

2012;25 Suppl 1:132‑3.

25. Gordon PV, Clark R. In response to the case report of allergic enterocolitis in a preterm neonate: How prevalent is systemic eosinophilia with NEC? J Perinatol 2011; 31:297 8.

26. Sharma R, Tepas JJ 3rd, Hudak ML, Mollitt DL, Wludyka PS, Teng RJ, et al. Neonatal gut barrier and multiple organ failure: Role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007;42:454‑61.

27. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: Recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008; 32:70‑82.

28. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl

Acad Sci U S A 2000; 97:6043‑8.

29. Good M, Sodhi C, Siggers R, Prindle T, Branca M, Russo A, et al Epithelial growth factor attenuates the severity of experimental necrotizing enterocolitis and inhibits toll-like receptor 4 signaling in Enterocytes. E-PAS 2011:2720-3.

30. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence for an innate immune response in the immature human intestine: Toll like receptors on fetal Enterocytes. Pediatr Res 2001;49:589‑93.

31. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated Ikappa B expression in intestinal epithelium and susceptibility to flagellin induced inflammation. Proc Natl Acad Sci U S A 2004; 101:7404‑8.

32. Rognum TO, Thrane S, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992; 32:145‑9.

33. Emami CN, Mittal R, Wang L, Ford HR, Prasadarao NV. Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii. J Surg Res 2012; 172:18‑28.

34. Martin CR, Walker WA. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med 2006;11:369‑77.

35. Uhlig HH, Powrie F. The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin Immunopathol 2005;27:167‑80.

36. Neu J, Chen M, Beierle E. Intestinal innate immunity: How does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005; 14:137‑44.

37. Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A 2009;106:19256‑61.

38. Claud EC, Walker AW. The intestinal microbiota and the microbiome. New York: Saunders; 2008.

39. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, et al. The antibacterial lectin Reg III gamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011; 334:255‑8.

40. Rakoff Nahoum S, Paglino J, Eslami Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll like receptors is required for intestinal homeostasis. Cell 2004; 118:229‑41.

41. Abreu MT. Toll like receptor signaling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10:131‑44.

42. Cario E, Gerken G, Podolsky DK. Toll like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132:1359‑74.

43. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: An immature innate immune response. PLoS One 2011; 6:e17776.

44. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006; 203:973‑84.

45. Michalsky MP, Lara Márquez M, Chun L, Besner GE. Heparin binding EGF like growth factor is present in human amniotic fluid and breast milk. J Pediatr Surg 2002; 37:1‑6.

46. Feng J, El Assal ON, Besner GE. Heparin binding epidermal growth factor like growth factor decreases the incidence of necrotizing enterocolitis in rats with NEC. J Pediatr Surg 2007; 42:214‑20.

47. Feng J, El Assal ON, Besner GE. Heparin binding epidermal growth factor like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2006; 41:144‑9.

48. Kuhn MA, Xia G, Mehta VB, Glenn S, Michalsky MP, Besner GE. Heparin binding EGF like growth factor (HB‑EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal 2002; 4:639‑46.

49. Rocourt M, Mehta V, Besner G. Heparin binding EGF like growth factor (HB‑EGF) decreases neutrophil endothelial cell interaction. J Pediatr Surg 2007; 139:269‑73.

50. El Assal ON, Besner GE. Heparin binding epidermal growth factor like growth factor and intestinal ischemia reperfusion injury. Semin Pediatr Surg 2004; 13:2‑10.

51. El Assal ON, Radulescu A, Besner GE. Heparin binding EGF like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery 2007; 142:234‑42.

52. Neish AS. Molecular aspects of intestinal epithelial cell bacterial interactions that determine the development of intestinal inflammation. Inflamm Bowel Dis 2004; 10:159‑68.

53. Hand IL, Noble L, McVeigh TJ, Kim M, Yoon JJ. The effects of intrauterine cocaine exposure on the respiratory status of the very low birth weight infant. J Perinatol 2001; 21:372‑5.

54. Bashiri A, Zmora E, Sheiner E, Hershkovitz R, Shoham‑Vardi I, Mazor M. Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. Fetal Diagn Ther 2003; 18:404‑7.

55. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med

2003;13:102‑9.

56. Desfrere L, de Oliveira I, Goffinet F, El Ayoubi M, Firtion G, Bavoux F, et al. Increased incidence of necrotizing enterocolitis in premature infants born to HIV positive mothers. AIDS 2005; 19:1487‑93.

57. Nowicki PT, Nankervis CA. The role of the circulation in the pathogenesis of necrotizing enterocolitis. Clin Perinatol 1994; 21:219‑34.

58. Warner BB, Ryan AL, Seeger K, Leonard AC, Erwin CR, Warner BW. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 2007;150:358‑60.

59. Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. The intestinal bacterial colonisation in preterm infants: A review of the literature. Clin Nutr 2006; 25:361‑8.

60. Gregory KE. Clinical predictors of necrotizing enterocolitis in premature infants. Nurs Res 2008; 57:260‑70.

61. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58‑66.

62. Kuppala VS, Meinzen Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011;159:720‑5.

63. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159:392‑7.

64. Chong E, Reynolds J, Shaw J, Forur L, Delmore P, Uner H, et al. Results of a two center, before and after study of piperacillin tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤1500 g. J Perinatol 2013;33:529‑32.

65. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: A population based study. J Pediatr Gastroenterol Nutr 2005; 40:184‑8.

66. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD004213. DOI: 10.1002/14651858.CD004213.pub3.